| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.3 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |